DavidM.FaleckMD
Gastroenterology • New York, NYInflammatory Bowel Disease
Attending Gastroenterologist
Dr. Faleck is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1275 York Avenue
New York, NY 10065- Is this information wrong?
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Gastroenterology, 2015 - 2018
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 2012 - 2015
Albert Einstein College of MedicineClass of 2012
University of PennsylvaniaBA, Biology, Jewish Studies, summa cum laude, 2004 - 2008
Certifications & Licensure
FL State Medical License 2021 - Present
NJ State Medical License 2022 - 2025
NY State Medical License 2015 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Member AOA, 2012
- Member Phi Beta Kappa, 2007
Clinical Trials
- Stool Transplant to Control Treatment-related Diarrhea Start of enrollment: 2021 May 10
Publications & Presentations
PubMed
- Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis.Pooja Middha, Rohit Thummalapalli, Michael J Betti, Lydia Yao, Zoe Quandt, Karmugi Balaratnam, Cosmin A Bejan, Eduardo Cardenas, Christina J Falcon, David M Faleck, , ...> ;Nature Communications. 2024 Mar 26
- 1 citationsImmune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation.Elkrief, A., Waters, N., Smith, N., Dai, A., Slingerland, J., Aleynick, N., Febles, B., Gogia, P., Socci, N., Lumish, M., Giardina, P., Chaft, J., Eng, J., Motzer, R.,...> ;Cancer Immunology Research. 2024 Mar 4
- Novel endoscopic scoring system for immune mediated colitis: A Multicenter Retrospective Study of 674 Patients.Wang, Y., Abu-Sbeih, H., Tang, T., Shatila, M., Faleck, D., Harris, J., Dougan, M., Olsson-Brown, A., Johnson, D., Shi, C., Grivas, P., Diamantopoulos, L., Owen, D., C...> ;Gastrointestinal Endoscopy. 2024 Jan 23
- Join now to see all
Journal Articles
- Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY ConsortiumLeah Katta, Robert Hirten, Shannon Chang, Dana Lukin, Edward V Loftus, David Faleck, Arun Swaminath, William J Sandborn, Sashidhar Varma Sagi, Sunanda Kane, Prianka Ch..., Nature
- Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY ConsortiumGursimran Kochhar, Justin Hartke, Sashidhar Varma Sagi, Edward V Loftus, Joseph Meserve, Robert Hirten, David Faleck, Shannon Chang, Dana Lukin, Farhad Peerani, Leah K..., Nature
Hospital Affiliations
Memorial Sloan Kettering Cancer CenterNew York, New York- Memorial Hospital for Cancer and allied DiseasesBasking Ridge, New Jersey
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
